Clinical trialNCT04119024RecruitingPhase 1Interventional

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

SponsorAnusha KalbasiEnrollment18Acral MelanomaAdrenocortical CarcinomaBreast CancerHead and Neck Squamous Cell CarcinomaLung AdenocarcinomaMetastatic Malignant Solid Neoplasm+11 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Allison Betof Warner, MD, PhD
Stanford University
Principal Investigator
clinicaltrials.gov ↗
Antoni Ribas, MD, PhD
University of California, Los Angeles
Principal Investigator
clinicaltrials.gov ↗
Yan Xing, MD, PhD
City of Hope Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope
Duarte, California, United States
Yan Xing, MD, Phd
Recruiting
Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
Antoni Ribas, MD, PhD
Recruiting
Stanford Cancer Institute
Stanford, California, United States
Allison Betof Warner, MD, PhD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 Oct 2025
Primary completion: 31 Oct 2026
Completion: 31 Oct 2026
Last update posted: 17 Mar 2026
Registered enrollment: 18
Registry id: NCT04119024

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.